1 - 25 of
77
results
for author:"Gomez L."
in Literature Citations
| Association of attention-deficit/hyperactivity disorder with a candidate region for reading disabilities on chromosome 6p. Couto J.M., Gomez L., Wigg K., Ickowicz A., Pathare T., Malone M., Kennedy J.L., Schachar R., Barr C.L. Biol. Psychiatry 66:368-375(2009) · Mapped (4) |
| BCL2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Delgado-Vega A.M., Castiblanco J., Gomez L.M., Diaz-Gallo L.M., Rojas-Villarraga A., Anaya J.M. Ann. Rheum. Dis. 0:0-0(2009) · Mapped (8) |
| Dynamic interaction of hTRPC6 with the Orai1-STIM1 complex or hTRPC3 mediates its role in capacitative or non-capacitative Ca(2+) entry pathways. Jardin I., Gomez L.J., Salido G.M., Rosado J.A. Biochem. J. 420:267-276(2009) · Mapped (9) |
| Isolation of a new fungi and wound-induced chitinase class in corms of Crocus sativus. Lopez R.C., Gomez-Gomez L. Plant Physiol. Biochem. 47:426-434(2009) · UniProtKB (1) |
| G72/G30 (DAOA) and juvenile-onset mood disorders. Gomez L., Wigg K., Feng Y., Kiss E., Kapornai K., Tamas Z., Mayer L., Baji I., Daroczi G., Benak I. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B:1007-1012(2009) · Mapped (6) |
| The KIAA0319-like (KIAA0319L) gene on chromosome 1p34 as a candidate for reading disabilities. Couto J.M., Gomez L., Wigg K., Cate-Carter T., Archibald J., Anderson B., Tannock R., Kerr E.N., Lovett M.W., Humphries T. et al. J. Neurogenet. 22:295-313(2008) · Mapped (6) |
| Tagging SNP association study of the IL-1beta gene (IL1B) and childhood-onset mood disorders. International Consortium for Childhood-Onset Mood Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B:653-659(2009) · Mapped (3) |
| Cytokine Genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. International Consortium for Childhood-Onset Mood Disorders Neuropsychobiology 58:71-80(2008) · Mapped (21) |
| Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat. Font-Llitjos M., Rodriguez-Santiago B., Espino M., Sillue R., Manas S., Gomez L., Perez-Jurado L.A., Palacin M., Nunes V. Eur. J. Hum. Genet. 17:71-79(2009) · Mapped (3) |
| Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment. Martinez A., Hinz J.M., Gomez L., Molina B., Acuna H., Jones I.M., Frias S., Coleman M.A. Mutat. Res. 656:1-7(2008) · Mapped (31) |
| Cytosolic and plastoglobule-targeted carotenoid dioxygenases from Crocus sativus are both involved in beta-ionone release. Rubio A., Rambla J.L., Santaella M., Gomez M.D., Orzaez D., Granell A., Gomez-Gomez L. J. Biol. Chem. 283:24816-24825(2008) · UniProtKB (3) |
| Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Rojas-Villarraga A., Ortega-Hernandez O.D., Gomez L.F., Pardo A.L., Lopez-Guzman S., Arango-Ferreira C., Hincapie M.E., Betancur J.F., Pineda-Tamayo R., Diaz F.J. et al. Semin. Arthritis Rheum. 38:71-82(2008) · Mapped (458) |
| Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases. Aragon L.M., Mirelis B., Miro E., Mata C., Gomez L., Rivera A., Coll P., Navarro F. J. Antimicrob. Chemother. 61:1029-1032(2008) · UniProtKB (3) |
| Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility. Sole X., Hernandez P., de Heredia M.L., Armengol L., Rodriguez-Santiago B., Gomez L., Maxwell C.A., Aguilo F., Condom E., Abril J. et al. BMC Genomics 9:12-12(2008) · Mapped (8) |
| CD209 in inflammatory bowel disease: a case-control study in the Spanish population. Nunez C., Oliver J., Mendoza J.L., Gomez-Garcia M., Taxonera C., Gomez L.M., Lopez-Nevot M.A., de la Concha E.G., Urcelay E., Martinez A. et al. BMC Med. Genet. 8:75-75(2007) · Mapped (463) |
| New polymorphism in the NCF-2 gene leading to alternative splicing without altering gene expression or the respiratory burst activity. Gomez L.A., Rugeles M.T., Patino P.J., Condino Neto A. Am. J. Hematol. 83:172-172(2008) · Mapped (7) |
| A single nucleotide polymorphism in the promoter region of theNCF-2 gene. Gomez L.A., Patino P.J., Novaira H.J., Morales M.M., Condino-Neto A. Am. J. Hematol. 82:1124-1125(2007) · Mapped (7) |
| TNF microsatellites polymorphism is associated with rheumatoid arthritis. Confirming evidence in northwestern Colombians. Gomez L.M., Ruiz-Narvaez E.A., Pineda-Tamayo R., Rojas-Villarraga A., Anaya J.M. Clin. Exp. Rheumatol. 25:443-448(2007) · Mapped (696) |
| Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina. Gomez L.C., Real S.M., Ojeda M.S., Gimenez S., Mayorga L.S., Roque M. BMC Med. Genet. 8:39-39(2007) · Mapped (1) |
| Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. Gomez L.M., Sanchez E., Ruiz-Narvaez E.A., Lopez-Nevot M.A., Anaya J.M., Martin J. Tissue Antigens 70:28-33(2007) · Mapped (1) |
| Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalence. Navarro F., Mesa R.J., Miro E., Gomez L., Mirelis B., Coll P. FEMS Microbiol. Lett. 273:120-123(2007) · UniProtKB (1) |
| Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy. Gomez L.A., de Las Pozas A., Reiner T., Burnstein K., Perez-Stable C. Mol. Cancer Ther. 6:1534-1543(2007) · Mapped (8) |
| A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Gomez L.M., Anaya J.M., Vilchez J.R., Cadena J., Hinojosa R., Velez L., Lopez-Nevot M.A., Martin J. Tuberculosis (Edinb) 87:288-294(2007) · Mapped (3) |
| The gene for synapsin III and attention-deficit hyperactivity disorder. Makkar R., Gomez L., Wigg K.G., Ickowicz A., Pathare T., Tannock R., Malone M., Kennedy J.L., Schachar R., Barr C.L. Psychiatr. Genet. 17:109-112(2007) · Mapped (6) |
| Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Pujana M.A., Ruiz A., Badenas C., Puig-Butille J.-A., Nadal M., Stark M., Gomez L., Valls J., Sole X., Hernandez P. et al. Genes Chromosomes Cancer 46:155-162(2007) · UniProtKB (1) |
